-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Kiromic Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to 2023.
- Kiromic Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$5.7M, a 38.1% decline year-over-year.
- Kiromic Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$21.2M, a 10.6% increase from 2022.
- Kiromic Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$23.7M, a 16.9% decline from 2021.
- Kiromic Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$20.3M, a 232% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)